News & Events:VEEV

Veeva Sys has outperformed the market over the past 5 years by 18.73% on an annualized basis producing an average annual return of 29.58%. Currently, Veeva Sys has a market capitalization of $35.54 billion. Buying $100 In VEEV: If an investor had bought $100 of VEEV stock 5 years ago, it would be worth $363.25 today based on a price of $229.50 for VEEV at the time of writing.

PLEASANTON, Calif. Veeva (VEEV) will post prepared remarks to its investor relations website at https://ir.veeva.com approximately at 1:05 p.m. PT. A webcast replay will be available on the website following the live event. Veeva (VEEV) is the global leader in cloud software for the life sciences industry.

  See all analyst ratings upgrades.   See all analyst ratings downgrades.   See all analyst ratings initiations.

Data from over 130 million quarterly HCP-field interactions across 80% of global biotech and pharma companies unveiled in Veeva Pulse Field Trends Report Industrywide data shows frequent use of key digital channels is vital for effective HCP engagement PLEASANTON, Calif. Analysis of the data shows frequent use of key digital channels is vital for effective HCP engagement.

Veeva Sys has outperformed the market over the past 5 years by 15.77% on an annualized basis producing an average annual return of 25.46%. Currently, Veeva Sys has a market capitalization of $31.66 billion. Buying $100 In VEEV: If an investor had bought $100 of VEEV stock 5 years ago, it would be worth $323.71 today based on a price of $204.49 for VEEV at the time of writing.

Analysts have provided the following ratings for Veeva Sys within the last quarter: In the last 3 months, 10 analysts have offered 12-month price targets for Veeva Sys. Below is a summary of how these 10 analysts rated Veeva Sys over the past 3 months.

Veeva Systems Inc (VEEV): * COURT REJECTS MEDIDATA LAWSUIT AGAINST VEEVA FOR LACK OF EVIDENCE, BLOCKS MEDIDATA'S MOVES TO LIMIT COMPETITION AND EMPLOYEE RIGHTS Source text for Eikon: Further company coverage:

Dassault Systemes SE: * VEEVA SYSTEMS INC (VEEV) - COURT OF HAS DISMISSED TRADE SECRET MISAPPROPRIATION LAWSUIT FILED BY MEDIDATA, A DASSAULT SYSTÈMES COMPANY, AGAINST CO Source text for Eikon: Further company coverage:

Major win for employee rights and the life sciences industry as court ends Medidata's moves to stifle innovation and free flow of talent NEW YORK and PLEASANTON, Calif.

According to HSBC, the prior rating for KE Holdings Inc was changed from Hold to Buy. According to Raymond James, the prior rating for Frontier Group Holdings Inc was changed from Market Perform to Outperform. According to Raymond James, the prior rating for Southwest Airlines Co was changed from Outperform to Strong Buy.

Within the last quarter, Veeva Sys has observed the following analyst ratings: In the last 3 months, 8 analysts have offered 12-month price targets for Veeva Sys. Below is a summary of how these 8 analysts rated Veeva Sys over the past 3 months.

Partnership drives commercial excellence through precision engagement to benefit patients in need of options BAUDETTE, Minn. and PLEASANTON, Calif. "To serve rare disease patients with high unmet medical needs, we need to be agile, data-driven, and efficient," said Christopher Mutz, head of rare disease at ANI.

On CNBC's "Halftime Report Final Trades," Pete Najarian said he bought the August 320 puts in SPDR S&P 500 ETF Trust. Jason Snipe of Odyssey Capital Advisors said he liked Dollar General Corp. in the backdrop of high inflation and supply chain issues. Check out other stocks making moves in the premarket.

Someone with a lot of money to spend has taken a bearish stance on Veeva Sys. And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know. So how do we know what this whale just did?

Shares of Oracle Corporation are trading higher Tuesday after the company reported fourth-quarter earnings results after market close Monday. The Oracle Analysts: Bank of America analyst Brad Sills had a Neutral rating on Oracle and a price target of $90. BMO Capital analyst Keith Bachman had a Market Perform rating and lowered the price target from $92 to $86.

Veeva Vault Study Training unifies learning management and clinical operations for integrated and automated training and real-time inspection readiness PLEASANTON, Calif.

Veeva Sys has outperformed the market over the past 5 years by 12.51% on an annualized basis producing an average annual return of 23.58%. Currently, Veeva Sys has a market capitalization of $29.23 billion. Buying $100 In VEEV: If an investor had bought $100 of VEEV stock 5 years ago, it would be worth $287.42 today based on a price of $188.84 for VEEV at the time of writing.

* Microsoft (MSFT) trims forecast due to FX impact. * ADP May private sector jobs +128,000 vs est +300,000. By Noel Randewich and Anisha Sircar. Wall Street ended sharply higher on Thursday, led by Tesla, Nvidia (NVDA) and other megacap growth stocks in a choppy session ahead of a key jobs report due on Friday. Tesla, Nvidia (NVDA) and Meta Platforms (FB) each rose sharply, fueling gains in the S&P 500 and Nasdaq.

Over the past 3 months, 8 analysts have published their opinion on Veeva Sys stock. In the last 3 months, 8 analysts have offered 12-month price targets for Veeva Sys. Below is a summary of how these 8 analysts rated Veeva Sys over the past 3 months.